Literature DB >> 19110029

Ciglitazone induces apoptosis via activation of p38 MAPK and AIF nuclear translocation mediated by reactive oxygen species and Ca(2+) in opossum kidney cells.

Chae Hwa Kwon1, Ji Yeon Park, Thae Hyun Kim, Jae Suk Woo, Yong Keun Kim.   

Abstract

We have previously demonstrated that the synthetic peroxisome proliferator-activated receptor-gamma (PPARgamma) agonist ciglitazone induces apoptosis accompanied by activation of p38 mitogen-activated protein kinase (MAPK) and nuclear translocation of apoptosis inducing factor (AIF) in opossum kidney (OK) renal epithelial cells. However, the precise mechanism by which ciglitazone induces activation of p38 MAPK and the role of AIF in the induction of the apoptosis are not defined. This study was therefore undertaken to determine whether the roles of reactive oxygen species (ROS) generation and intracellular Ca(2+) in the ciglitazone-induced activation of p38 MAPK and whether AIF nuclear translocation is responsible for the ciglitazone-induced apoptosis in OK renal epithelial cells. Ciglitazone caused generation of ROS and an increase in intracellular Ca(2+). Ciglitazone-induced cell death was reduced by the antioxidant Trolox, the Ca(2+) chelator EGTA, and the store-operated Ca(2+) channels (SOCC) blocker lanthanum chloride (La(3+)), indicating involvement of ROS and Ca(2+) in the ciglitazone-induced cell death. Ciglitazone-induced intracellular Ca(2+) increase was decreased by Trolox, while ROS generation was not affected by EGTA and La(3+), suggesting that ROS generation promote the increase of intracellular Ca(2+). Transfection of small interfering RNA (siRNA) of p38 MAPK or vector expressing microRNA (miRNA) of AIF prevented the ciglitazone-induced cell death. Activation of p38 MAPK, mitochondrial membrane depolarization, and AIF nuclear translocation induced by ciglitazone were inhibited by Trolox, EGTA and La(3+). Taken together, these results suggest that ROS-dependent intracellular Ca(2+) increase is responsible for activation of p38 MAPK and nuclear translocation of AIF by ciglitazone.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19110029     DOI: 10.1016/j.tox.2008.11.019

Source DB:  PubMed          Journal:  Toxicology        ISSN: 0300-483X            Impact factor:   4.221


  6 in total

Review 1.  Apoptosis-inducing factor: structure, function, and redox regulation.

Authors:  Irina F Sevrioukova
Journal:  Antioxid Redox Signal       Date:  2011-03-10       Impact factor: 8.401

2.  Intensive stretch-activated CRT-PMCA1 feedback loop promoted apoptosis of myoblasts through Ca2+ overloading.

Authors:  Dapeng Ren; Ran Liu; Xiao Yan; Qiang Zhang; Xuemin Zeng; Xiao Yuan
Journal:  Apoptosis       Date:  2022-08-17       Impact factor: 5.561

3.  Manganese superoxide dismutase is a promising target for enhancing chemosensitivity of basal-like breast carcinoma.

Authors:  Alan Prem Kumar; Ser Yue Loo; Sung Won Shin; Tuan Zea Tan; Chon Boon Eng; Rajeev Singh; Thomas Choudary Putti; Chee Wee Ong; Manuel Salto-Tellez; Boon Cher Goh; Joo In Park; Jean Paul Thiery; Shazib Pervaiz; Marie Veronique Clement
Journal:  Antioxid Redox Signal       Date:  2013-11-14       Impact factor: 8.401

4.  Calpain inhibitor PD150606 attenuates glutamate induced spiral ganglion neuron apoptosis through apoptosis inducing factor pathway in vitro.

Authors:  Zhong-Jia Ding; Xin Chen; Xiao-Xu Tang; Xi Wang; Yong-Li Song; Xiao-Dong Chen; Wen-Juan Mi; Jian Wang; Ying Lin; Fu-Quan Chen; Jian-Hua Qiu
Journal:  PLoS One       Date:  2015-04-15       Impact factor: 3.240

5.  Arctigenin Enhances the Cytotoxic Effect of Doxorubicin in MDA-MB-231 Breast Cancer Cells.

Authors:  Kyu-Shik Lee; Min-Gu Lee; Yun-Suk Kwon; Kyung-Soo Nam
Journal:  Int J Mol Sci       Date:  2020-04-23       Impact factor: 5.923

6.  Role of TLR4/NADPH oxidase/ROS-activated p38 MAPK in VCAM-1 expression induced by lipopolysaccharide in human renal mesangial cells.

Authors:  I-Ta Lee; Ruey-Horng Shih; Chih-Chung Lin; Jung-Tsan Chen; Chuen-Mao Yang
Journal:  Cell Commun Signal       Date:  2012-11-15       Impact factor: 5.712

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.